Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?

29.01.25 15:40 Uhr

Werte in diesem Artikel
Aktien

29,20 EUR -0,60 EUR -2,01%

Indizes

19.523,4 PKT -268,6 PKT -1,36%

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.One company to watch right now is USANA Health Sciences (USNA). USNA is currently sporting a Zacks Rank of #1 (Strong Buy) and an A for Value.Investors should also note that USNA holds a PEG ratio of 0.92. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. USNA's industry currently sports an average PEG of 2.06. Over the past 52 weeks, USNA's PEG has been as high as 1.54 and as low as 0.90, with a median of 1.29.Another valuation metric that we should highlight is USNA's P/B ratio of 1.23. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. USNA's current P/B looks attractive when compared to its industry's average P/B of 1.29. Over the past 12 months, USNA's P/B has been as high as 2.01 and as low as 1.19, with a median of 1.61.Finally, our model also underscores that USNA has a P/CF ratio of 8.68. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. USNA's current P/CF looks attractive when compared to its industry's average P/CF of 8.90. Over the past year, USNA's P/CF has been as high as 11.97 and as low as 8.43, with a median of 10.33.These figures are just a handful of the metrics value investors tend to look at, but they help show that USANA Health Sciences is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, USNA feels like a great value stock at the moment.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report USANA Health Sciences, Inc. (USNA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf USANA Health Sciences

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf USANA Health Sciences

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu USANA Health Sciences Inc.

Wer­bung

Analysen zu USANA Health Sciences Inc.

DatumRatingAnalyst
16.04.2019USANA Health Sciences BuyTigress Financial
24.10.2018USANA Health Sciences BuyPivotal Research Group
23.04.2018USANA Health Sciences HoldPivotal Research Group
07.02.2018USANA Health Sciences BuyPivotal Research Group
25.10.2017USANA Health Sciences BuyPivotal Research Group
DatumRatingAnalyst
16.04.2019USANA Health Sciences BuyTigress Financial
24.10.2018USANA Health Sciences BuyPivotal Research Group
07.02.2018USANA Health Sciences BuyPivotal Research Group
25.10.2017USANA Health Sciences BuyPivotal Research Group
26.07.2017USANA Health Sciences BuyPivotal Research Group
DatumRatingAnalyst
23.04.2018USANA Health Sciences HoldPivotal Research Group
01.05.2017USANA Health Sciences HoldPivotal Research Group
06.08.2015USANA Health Sciences NeutralD.A. Davidson & Co.
23.04.2015USANA Health Sciences HoldCanaccord Adams
30.10.2014USANA Health Sciences HoldCanaccord Adams
DatumRatingAnalyst
29.04.2010USANA "underperform"Wedbush Morgan Securities Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für USANA Health Sciences Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"